80 results
8-K
EX-99.1
SAGE
Sage Therapeutics Inc
25 Apr 24
Sage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress
6:46am
for a majority of commercially covered lives for ZURZUVAE in the treatment of women with postpartum depression (PPD) without step therapy or complex prior … , particularly OBGYNs, and hearing inspiring success stories from women with PPD treated with ZURZUVAE. Importantly, momentum in commercial and government payor
8-K
EX-99.1
SAGE
Sage Therapeutics Inc
14 Feb 24
Sage Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Highlights Pipeline and Business Progress
6:45am
with the early progress on the launch. I am proud of our team’s relentless work toward our goal of ZURZUVAE becoming the first line therapy for women … by the FDA in August 2023. Efforts to establish ZURZUVAE as the first line therapy and standard of care for women with PPD are underway.
In November 2023
8-K
EX-99.2
5th jok3yyhpsotiwsw
8 Jan 24
Departure of Directors or Certain Officers
6:45am
PRE 14A
n7pe3nakk 9exk
8 Dec 23
Preliminary proxy
8:30am
424B5
mlkg y641fe
7 Nov 23
Prospectus supplement for primary offering
7:29am
8-K
EX-99.1
hxy13k1jdz4keg6ti
7 Nov 23
Sage Therapeutics Announces Third Quarter 2023 Financial Results and Highlights Pipeline and Business Progress
6:46am
8-K
n89pcz2l
31 Aug 23
Cost Associated with Exit or Disposal Activities
6:45am
8-K
EX-99.1
shrpk2htkiq5k90 p7
7 Aug 23
Sage Therapeutics Announces Second Quarter 2023 Financial Results and Highlights Pipeline and Business Progress
6:45am
8-K
EX-99.1
jpiwv jayd
6 Dec 22
Other Events
6:51am
8-K
p1var1uu xbjdom6
13 Jun 22
Other Events
7:01am